| Financial Year |
March 31 2023 |
| Monetary Funds |
311,609,538.92 |
| Held-for-trading Financial Assets |
41,242,962.16 |
| Notes Receivable |
301,880.78 |
| Accounts Receivable |
91,701,214.19 |
| Advances to Suppliers |
25,137,800.36 |
| Other Receivables |
8,367,777.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
188,327,503.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,858,212.90 |
| Total Current Assets |
720,966,043.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,744,378.73 |
| Investment Properties |
48,727,269.13 |
| Fixed Assetes |
202,540,246.30 |
| Under-construction Projects |
104,671,998.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,408,752.59 |
| R&D expenses |
-- |
| Goodwill |
28,098,558.03 |
| Long-Term Deferred and Prepaid Expenses |
15,091,000.71 |
| Deferred Income Tax Assets |
36,059,401.41 |
| Other Non-Current Assets |
8,903,682.85 |
| Sub-Total of Non-Current Assets |
577,969,364.58 |
| Total Assets |
1,298,935,407.70 |
| Short-Term Loans |
32,555,686.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
81,113,521.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,652,880.47 |
| Taxes Payable |
2,971,091.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,669,042.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,264,412.64 |
| Other Current Liabilities |
6,028,914.18 |
| Sub-Total of Current Liabilities |
306,635,199.02 |
| Long-term Loans |
65,379,605.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
377,000.00 |
| Deferred Income Tax Liabilities |
6,568,619.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
88,103,596.56 |
| Total Liabilities |
394,738,795.58 |
| Paid-In Capital(Or Share Stock) |
368,717,683.00 |
| Capital Surplus |
294,588,158.26 |
| Surplus Reserve |
25,575,692.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
179,210,585.42 |
| Minority Stockholder's Interest |
34,251,663.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
869,944,949.04 |
| Owner's Equity（Stockholder's Equity） |
904,196,612.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,298,935,407.70 |
